Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Hong-liang Dou"'
Publikováno v:
BMC Ophthalmology, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Purpose Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a relatively rare subtype of DLBCL. Herein, we report a case of a patient with EBV-positive iris DLBCL after undergoing penetrating keratoplasty and discuss i
Externí odkaz:
https://doaj.org/article/4a0a0735af9c447da6dc5022a05ccb34
Publikováno v:
Guoji Yanke Zazhi, Vol 21, Iss 8, Pp 1473-1478 (2021)
AIM: To evaluate the effect of Conbercept or Aflibercept on macular perfusion status in patients with diabetic macular edema(DME), and the changes in foveal avascular zone(FAZ)areas and capillary density in macular regions were measured quantitativel
Externí odkaz:
https://doaj.org/article/61eff81aaad94b29bfc8c7dfae45843e
Autor:
Hui-Jin Chen, Chang-Guan Wang, Hong-Liang Dou, Xue-Feng Feng, Kang Feng, Yun-Tao Hu, Yi-Min Xu, Zhi-Zhong Ma
Publikováno v:
Journal of Ophthalmology, Vol 2014 (2014)
Externí odkaz:
https://doaj.org/article/bb6d954c8b0246bb8bc707d52e0659c1
Autor:
Chun Zhang, Hong Liang Dou, Dong Ning Chen, Jing Cui, Can Can Xue, Jost B. Jonas, Li Qin Gao, Ya Xing Wang
Publikováno v:
American Journal of Ophthalmology. 227:143-153
To assess potential associations between the prevalence of age-related macular degeneration (AMD) and systemic parameters in a Chinese population.Cross-sectional study.The Tongren Health Care Study included individuals attending regular health care c
Autor:
Fei-Fei Huang, Xin-Rong Lu, Hong-Liang Dou, Xiao-Ming Lin, Zhiyong Zou, Yang-Mu Huang, Xian-Rong Xu
Publikováno v:
British Journal of Ophthalmology. 99:371-375
To investigate functional and macular pigment (MP) changes in patients with early age-related macular degeneration (AMD) after multiple supplementation with lutein and zeaxanthin.112 patients with early AMD were randomly (1:1:1:1) assigned to receive
Autor:
Yang-Mu Huang, Le Ma, Hong-Liang Dou, Xiao-Ming Lin, Xian-Rong Xu, Shao-Fang Yan, Zhiyong Zou
Publikováno v:
Nutrition. 29:387-392
This randomized controlled trial examined serum and macular (in vivo measured macular pigment optical density [MPOD]) responses to supplemental lutein and zeaxanthin in Chinese subjects with early age-related macular degeneration.One hundred and eigh
Autor:
Xiao-Ming Lin, Hong-Liang Dou, Le Ma, Zhiyong Zou, Yu-Bei Huang, Yang-Mu Huang, Xian-Rong Xu, Yi-Qun Wu
Publikováno v:
British Journal of Nutrition. 107:350-359
Lutein and zeaxanthin are thought to decrease the incidence of age-related macular degeneration (AMD); however, findings have been inconsistent. We conducted a systematic literature review and meta-analysis to evaluate the relationship between dietar
Publikováno v:
Ocular Immunology and Inflammation. 18:390-394
To investigate serum inflammatory factors in patients with idiopathic choroidal vascularization (CNV), including vascular endothelial growth factor (VEGF), tumor necrosis factor alpha (TNFα), Interleukin1-beta (IL1-β), IgG, IgA, IgM, IgE, 50% hemol
Autor:
Xuan Zhang, Zhizhong Ma, Hong-Liang Dou, Jian-Cheng Wang, Li Ma, Jun-Hui Xu, Qiang Zhang, Yu-Ling Liu
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 25:195-200
The objective of this study was to develop an efficient vasculature-targeted liposomal combretastatin A4 (CA4), by the modification of the sterically stabilized liposomes (SSL) with a ligand of integrins and to explore the possibility of such system
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2015 (2015)
BioMed Research International, Vol 2015 (2015)
Purpose. To compare the 2-year effect of multiple doses of lutein/zeaxanthin on serum, macular pigmentation, and visual performance on patients with early age-related macular degeneration (AMD).Methods. In this randomized, double-blinded, and placebo